13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Transfersomal eosin topical delivery assisted by fractional CO 2 laser for photodynamic treatment of palmar hyperhidrosis: case study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hyperhidrosis is a condition in which the cholinergic receptors on the eccrine glands are overstimulated, resulting in excessive sweating. It is considered a serious cosmetic and psychological problem that affects the patient’s quality of life. Searching for novel treatment modalities is required to minimize the side effects and to attain better patient satisfaction.

          Photodynamic therapy (PDT), using eosin as a photosensitizer, is developed as a promising modality of the treatment of palmar and axillary hyperhidrosis. In this study, we treated six cases suffering palmar hyperhidrosis by applying the fractional CO 2 laser prior to PDT session. For PDT, a hydrogel of eosin loaded in a transfersomes as a nano-delivery carrier was applied for 5 min, followed by irradiation by intense pulsed light (IPL). The prepared transfersomes loaded by eosin were spherical in shape with encapsulation efficiency of 33 ± 3.5%, particle size 305.5 ± 5.7 nm, average zeta potential of − 54 ± 7.6 mV with 80 ± 4% of the loaded eosin was released after 3 h. Two cases achieved 90% improvement after four sessions, three patients needed six sessions to show 75% improvement, while one patient showed only 25% improvement after six sessions. This resulted in shortening the time of PS application and decreasing the number of sessions required to achieve acceptable improvement. More clinical studies on large number of patients are required to optimize the results.

          Graphical abstract

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum

          The skin offers an accessible and convenient site for the administration of medications. To this end, the field of transdermal drug delivery, aimed at developing safe and efficacious means of delivering medications across the skin, has in the past and continues to garner much time and investment with the continuous advancement of new and innovative approaches. This review details the progress and current status of the transdermal drug delivery field and describes numerous pharmaceutical developments which have been employed to overcome limitations associated with skin delivery systems. Advantages and disadvantages of the various approaches are detailed, commercially marketed products are highlighted and particular attention is paid to the emerging field of microneedle technologies.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Photodynamic therapy of cancer. Basic principles and applications

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Enhancement strategies for transdermal drug delivery systems: current trends and applications

              Graphical abstract Transdermal drug delivery systems have become an intriguing research topic in pharmaceutical technology area and one of the most frequently developed pharmaceutical products in global market. The use of these systems can overcome associated drawbacks of other delivery routes, such as oral and parenteral. The authors will review current trends, and future applications of transdermal technologies, with specific focus on providing a comprehensive understanding of transdermal drug delivery systems and enhancement strategies. This article will initially discuss each transdermal enhancement method used in the development of first-generation transdermal products. These methods include drug/vehicle interactions, vesicles and particles, stratum corneum modification, energy-driven methods and stratum corneum bypassing techniques. Through suitable design and implementation of active stratum corneum bypassing methods, notably microneedle technology, transdermal delivery systems have been shown to deliver both low and high molecular weight drugs. Microneedle technology platforms have proven themselves to be more versatile than other transdermal systems with opportunities for intradermal delivery of drugs/biotherapeutics and therapeutic drug monitoring. These have shown that microneedles have been a prospective strategy for improving transdermal delivery systems.
                Bookmark

                Author and article information

                Contributors
                doaa.fadeel@niles.edu.eg
                Journal
                Drug Deliv Transl Res
                Drug Deliv Transl Res
                Drug Delivery and Translational Research
                Springer US (New York )
                2190-393X
                2190-3948
                20 April 2022
                20 April 2022
                2022
                : 12
                : 12
                : 3000-3006
                Affiliations
                [1 ]GRID grid.7776.1, ISNI 0000 0004 0639 9286, Pharmaceutical Technology Unit, Department of Medical Applications of Laser, , National Institute of Laser Enhanced Sciences (NILES), Cairo University, ; P.O. 12613, Giza, Egypt
                [2 ]GRID grid.7776.1, ISNI 0000 0004 0639 9286, Dermatology Unite, Department of Medical Applications of Laser, , National Institute of Laser Enhanced Sciences (NILES), Cairo University, ; P.O. 12613, Giza, Egypt
                [3 ]GRID grid.440865.b, ISNI 0000 0004 0377 3762, Department of Pharmacy Practice and Clinical Pharmacy, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, , Future University, ; Cairo, Egypt
                Author information
                http://orcid.org/0000-0002-2998-0239
                Article
                1164
                10.1007/s13346-022-01164-z
                9636100
                35441986
                f8d1edb1-c010-4146-9ccc-0ab7ae75f5bd
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit  http://creativecommons.org/licenses/by/4.0/.

                History
                : 4 April 2022
                Funding
                Funded by: Cairo University
                Categories
                Original Article
                Custom metadata
                © Controlled Release Society 2022

                Pharmacology & Pharmaceutical medicine
                hyperhidrosis,photodynamic therapy,eosin yellow photosensitizer,transfersomes

                Comments

                Comment on this article